Abacus Planning Group, Inc. Nuvation Bio Inc. Transaction History
Abacus Planning Group, Inc.
- $552 Million
- Q4 2024
A detailed history of Abacus Planning Group, Inc. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 16,611 shares of NUVB stock, worth $40,032. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,611Holding current value
$40,032% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
163Shares Held
157MCall Options Held
3.2KPut Options Held
98.7K-
Decheng Capital LLC Menlo Park, CA26MShares$62.6 Million14.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$46.3 Million1.92% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$39.1 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$31.5 Million44.61% of portfolio
-
Octagon Capital Advisors LP New York, NY12.2MShares$29.3 Million6.76% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $524M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...